Aldeyra Therapeutics Cash from Financing (TTM) Trends

Aldeyra Therapeutics Inc (ALDX)

3.87 -0.11 (-2.76%) USD | NASDAQ | Apr 19, 16:00

3.87 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-1.270M
September 30, 2023	-0.2579M
June 30, 2023	1.255M
March 31, 2023	1.249M
December 31, 2022	1.220M
September 30, 2022	1.220M
June 30, 2022	0.0871M
March 31, 2022	120.46M
December 31, 2021	194.50M
September 30, 2021	194.50M
June 30, 2021	220.66M
March 31, 2021	112.71M
December 31, 2020	41.90M
September 30, 2020	50.24M
June 30, 2020	38.86M
March 31, 2020	26.42M
December 31, 2019	23.58M
September 30, 2019	81.53M
June 30, 2019	67.80M
March 31, 2019	76.84M
December 31, 2018	80.53M

Date	Value
September 30, 2018	14.29M
June 30, 2018	40.00M
March 31, 2018	30.94M
December 31, 2017	37.43M
September 30, 2017	37.42M
June 30, 2017	10.49M
March 31, 2017	23.33M
December 31, 2016	12.74M
September 30, 2016	12.69M
June 30, 2016	12.75M
March 31, 2016	19.42M
December 31, 2015	28.47M
September 30, 2015	28.48M
June 30, 2015	28.34M
March 31, 2015	19.15M
December 31, 2014	10.06M
September 30, 2014	11.15M
June 30, 2014	13.27M
March 31, 2014	2.942M
December 31, 2013	3.745M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-1.270M

Minimum

Dec 2023

220.66M

Maximum

Jun 2021

61.93M

Average

38.86M

Median

Jun 2020

Cash from Financing (TTM) Benchmarks